Nomogram prediction for the overall survival and cancer-specific survival of patients diagnosed with Merkel cell carcinoma

被引:7
|
作者
Yin, Xufeng [1 ]
She, Huihui [1 ]
Carrero, Lorna Martin Kasyanju [1 ]
Ma, Weiwei [1 ]
Zhou, Bingrong [1 ]
机构
[1] Nanjing Med Univ, Affiliated Hosp 1, Dept Dermatol, Nanjing 210029, Peoples R China
关键词
Merkel cell carcinoma (MCC); nomogram; prognosis; survival; 8TH STAGING SYSTEM; RADIATION-THERAPY; CHEMOTHERAPY; EPIDEMIOLOGY; RADIOTHERAPY; MANAGEMENT;
D O I
10.21037/atm-20-4578
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Merkel cell carcinoma (MCC) is a rare and aggressive neuroendocrine carcinoma of the skin, with a high recurrence rate and a high mortality rate worldwide. The purpose of this article is to construct a nomogram that incorporates significant clinical parameters and predicts the survival of individuals with MCC. Methods: The Surveillance, Epidemiology, and End Results (SEER) database was employed to retrospectively analyze all confirmed MCC cases from 2004 to 2015. The data was collected from 3,688 patients, and was randomized as the training or validation group (1:1 ratio). The independent factors which predicted the cancer-specific survival (CSS) and overall survival (OS) for MCC cases were searched for nomogram construction respectively. Independent parameters that affected CSS were determined using the Fine and Gray competing risk regression model. In addition, the time-dependent receiver operating characteristic (ROC) curve was constructed. Then, the area under the curve (AUC) values, calibration curve, and the concordance index (C-index) were used to determine the nomogram performance. At last, decision curve analysis (DCA) was conducted to determine the net clinical benefit. Results: The multivariate analysis results revealed that sex, age, race, marriage, American Joint Committee on Cancer (AJCC) stage, chemotherapy and radiotherapy were independent OS prognostic factors. Furthermore, competing risk analysis showed age, sex, AJCC stage, chemotherapy were the independent CSS prognostic factors. For validation, the C-index value of OS nomogram was 0.703 (95% CI: 0.686-0.721), while C-index value of CSS nomogram was 0.737 (95% CI: 0.710-0.764). Both C-index and AUC suggested that nomograms had superior performance to that of the AJCC stage system. In addition, according to the calibration curve, both nomograms were capable of accurate prediction of MCC prognosis. The DCA showed that the net benefits of the nomograms were superior among various threshold probabilities than these of AJCC stage system. Conclusions: The present work established and verified the novel nomograms to predict the OS and CSS of MCC patients. If further confirmed in future studies, it may become another helpful tool for risk stratification and management of MCC patients.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] Can a Nomogram Help to Predict the Overall and Cancer-specific Survival of Patients With Chondrosarcoma?
    Song, Kehan
    Shi, Xiao
    Wang, Hongli
    Zou, Fei
    Lu, Feizhou
    Ma, Xiaosheng
    Xia, Xinlei
    Jiang, Jianyuan
    [J]. CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2018, 476 (05) : 987 - 996
  • [22] Prediction of cancer-specific survival and overall survival in middle-aged and older patients with rectal adenocarcinoma using a nomogram model
    Liu, Hao
    Lv, Liang
    Qu, Yidan
    Zheng, Ziweng
    Zhao, Junjiang
    Liu, Bo
    Zhang, Dasen
    Wang, Hexiang
    Zhang, Jian
    [J]. TRANSLATIONAL ONCOLOGY, 2021, 14 (01):
  • [23] Development and validation of nomograms for prediction of overall survival and cancer-specific survival of patients of colorectal cancer
    Zhang, Jieyun
    Yang, Yue
    Fu, Xiaojian
    Guo, Weijian
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2020, 50 (03) : 261 - 269
  • [24] A Nomogram for Predicting the Cancer-Specific Survival of Patients with Initially Diagnosed Metastatic Gastric Cancer
    Ren, Jun
    Dai, Yuedi
    Chao, Fei
    Tang, Dong
    Gu, Jiawei
    Niu, Gengming
    Xia, Jie
    Wang, Xin
    Song, Tao
    Hu, Zhiqing
    Hong, Runqi
    Ke, Chongwei
    [J]. CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2022, 16
  • [25] A Nomogram for Predicting the Cancer-Specific Survival of Patients with Initially Diagnosed Metastatic Gastric Cancer
    Ren, Jun
    Dai, Yuedi
    Chao, Fei
    Tang, Dong
    Gu, Jiawei
    Niu, Gengming
    Xia, Jie
    Wang, Xin
    Song, Tao
    Hu, Zhiqing
    Hong, Runqi
    Ke, Chongwei
    [J]. CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2022, 16
  • [26] Development and validation of Nomograms for predicting overall survival and Cancer-specific survival in patients with ovarian clear cell carcinoma
    Qian Chen
    Shu Wang
    Jing-He Lang
    [J]. Journal of Ovarian Research, 13
  • [27] Development and validation of Nomograms for predicting overall survival and Cancer-specific survival in patients with ovarian clear cell carcinoma
    Chen, Qian
    Wang, Shu
    Lang, Jing-He
    [J]. JOURNAL OF OVARIAN RESEARCH, 2020, 13 (01)
  • [28] Postoperative Nomogram for Predicting Cancer-Specific and Overall Survival among Patients with Medullary Thyroid Cancer
    Chen, Li
    Wang, Yizeng
    Zhao, Ke
    Wang, Yuyun
    He, Xianghui
    [J]. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2020, 2020
  • [29] Construction and validation of a nomogram for predicting cancer-specific survival in hepatocellular carcinoma patients
    Kang Liu
    Gaobo Huang
    Pengkang Chang
    Wei Zhang
    Tao Li
    Zhijun Dai
    Yi Lv
    [J]. Scientific Reports, 10
  • [30] Nomogram for predicting the overall survival and cancer-specific survival of patients with extremity liposarcoma: a population-based study
    Lin Ye
    Chuan Hu
    Cailin Wang
    Weiyang Yu
    Feijun Liu
    Zhenzhong Chen
    [J]. BMC Cancer, 20